Viatris’ Acquisition of Oyster Point Pharma

Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris.Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired by…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now